nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2C9—Ifosfamide—testicular cancer	0.137	0.276	CbGbCtD
Dolasetron—CYP3A4—Ifosfamide—testicular cancer	0.0797	0.16	CbGbCtD
Dolasetron—CYP2C9—Cisplatin—testicular cancer	0.0667	0.134	CbGbCtD
Dolasetron—CYP2D6—Vinblastine—testicular cancer	0.0665	0.134	CbGbCtD
Dolasetron—CYP3A4—Vinblastine—testicular cancer	0.0423	0.0851	CbGbCtD
Dolasetron—CYP2D6—Doxorubicin—testicular cancer	0.0409	0.0822	CbGbCtD
Dolasetron—CYP3A4—Etoposide—testicular cancer	0.0381	0.0766	CbGbCtD
Dolasetron—CYP3A4—Doxorubicin—testicular cancer	0.026	0.0523	CbGbCtD
Dolasetron—Chest pain—Etoposide—testicular cancer	0.000713	0.00142	CcSEcCtD
Dolasetron—Orthostatic hypotension—Epirubicin—testicular cancer	0.000712	0.00142	CcSEcCtD
Dolasetron—Anorexia—Cisplatin—testicular cancer	0.000711	0.00141	CcSEcCtD
Dolasetron—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000707	0.00141	CcSEcCtD
Dolasetron—Pancreatitis—Methotrexate—testicular cancer	0.000706	0.0014	CcSEcCtD
Dolasetron—Discomfort—Etoposide—testicular cancer	0.000704	0.0014	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.000702	0.0014	CcSEcCtD
Dolasetron—Hypotension—Cisplatin—testicular cancer	0.000697	0.00139	CcSEcCtD
Dolasetron—Face oedema—Doxorubicin—testicular cancer	0.000696	0.00138	CcSEcCtD
Dolasetron—Hypersensitivity—Dactinomycin—testicular cancer	0.000696	0.00138	CcSEcCtD
Dolasetron—Confusional state—Etoposide—testicular cancer	0.000689	0.00137	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.000687	0.00137	CcSEcCtD
Dolasetron—Urticaria—Ifosfamide—testicular cancer	0.000687	0.00137	CcSEcCtD
Dolasetron—Cardiac arrest—Doxorubicin—testicular cancer	0.000686	0.00136	CcSEcCtD
Dolasetron—Abdominal pain—Ifosfamide—testicular cancer	0.000684	0.00136	CcSEcCtD
Dolasetron—Body temperature increased—Ifosfamide—testicular cancer	0.000684	0.00136	CcSEcCtD
Dolasetron—Anaphylactic shock—Etoposide—testicular cancer	0.000683	0.00136	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000679	0.00135	CcSEcCtD
Dolasetron—Abdominal distension—Epirubicin—testicular cancer	0.000678	0.00135	CcSEcCtD
Dolasetron—Ataxia—Doxorubicin—testicular cancer	0.000678	0.00135	CcSEcCtD
Dolasetron—Asthenia—Dactinomycin—testicular cancer	0.000677	0.00135	CcSEcCtD
Dolasetron—Dysuria—Methotrexate—testicular cancer	0.000673	0.00134	CcSEcCtD
Dolasetron—Dehydration—Doxorubicin—testicular cancer	0.000671	0.00133	CcSEcCtD
Dolasetron—Paraesthesia—Cisplatin—testicular cancer	0.00067	0.00133	CcSEcCtD
Dolasetron—Thrombocytopenia—Etoposide—testicular cancer	0.000669	0.00133	CcSEcCtD
Dolasetron—Tachycardia—Etoposide—testicular cancer	0.000667	0.00133	CcSEcCtD
Dolasetron—Dyspnoea—Cisplatin—testicular cancer	0.000665	0.00132	CcSEcCtD
Dolasetron—Hyperhidrosis—Etoposide—testicular cancer	0.000661	0.00131	CcSEcCtD
Dolasetron—Pancreatitis—Epirubicin—testicular cancer	0.00066	0.00131	CcSEcCtD
Dolasetron—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000659	0.00131	CcSEcCtD
Dolasetron—Anorexia—Etoposide—testicular cancer	0.000651	0.0013	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000649	0.00129	CcSEcCtD
Dolasetron—Decreased appetite—Cisplatin—testicular cancer	0.000648	0.00129	CcSEcCtD
Dolasetron—Diarrhoea—Dactinomycin—testicular cancer	0.000646	0.00128	CcSEcCtD
Dolasetron—Pneumonia—Methotrexate—testicular cancer	0.000645	0.00128	CcSEcCtD
Dolasetron—Drowsiness—Methotrexate—testicular cancer	0.000642	0.00128	CcSEcCtD
Dolasetron—Hypotension—Etoposide—testicular cancer	0.000638	0.00127	CcSEcCtD
Dolasetron—Rash—Bleomycin—testicular cancer	0.000638	0.00127	CcSEcCtD
Dolasetron—Pain—Cisplatin—testicular cancer	0.000638	0.00127	CcSEcCtD
Dolasetron—Dermatitis—Bleomycin—testicular cancer	0.000638	0.00127	CcSEcCtD
Dolasetron—Hypersensitivity—Ifosfamide—testicular cancer	0.000637	0.00127	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000636	0.00126	CcSEcCtD
Dolasetron—Dysuria—Epirubicin—testicular cancer	0.00063	0.00125	CcSEcCtD
Dolasetron—Abdominal distension—Doxorubicin—testicular cancer	0.000627	0.00125	CcSEcCtD
Dolasetron—Stomatitis—Methotrexate—testicular cancer	0.000625	0.00124	CcSEcCtD
Dolasetron—Asthenia—Ifosfamide—testicular cancer	0.000621	0.00123	CcSEcCtD
Dolasetron—Feeling abnormal—Cisplatin—testicular cancer	0.000615	0.00122	CcSEcCtD
Dolasetron—Paraesthesia—Etoposide—testicular cancer	0.000614	0.00122	CcSEcCtD
Dolasetron—Pruritus—Ifosfamide—testicular cancer	0.000612	0.00122	CcSEcCtD
Dolasetron—Haematuria—Methotrexate—testicular cancer	0.000612	0.00122	CcSEcCtD
Dolasetron—Pancreatitis—Doxorubicin—testicular cancer	0.000611	0.00122	CcSEcCtD
Dolasetron—Dyspnoea—Etoposide—testicular cancer	0.000609	0.00121	CcSEcCtD
Dolasetron—Somnolence—Etoposide—testicular cancer	0.000607	0.00121	CcSEcCtD
Dolasetron—Epistaxis—Methotrexate—testicular cancer	0.000605	0.0012	CcSEcCtD
Dolasetron—Pneumonia—Epirubicin—testicular cancer	0.000604	0.0012	CcSEcCtD
Dolasetron—Drowsiness—Epirubicin—testicular cancer	0.000601	0.00119	CcSEcCtD
Dolasetron—Rash—Dactinomycin—testicular cancer	0.000595	0.00118	CcSEcCtD
Dolasetron—Decreased appetite—Etoposide—testicular cancer	0.000594	0.00118	CcSEcCtD
Dolasetron—Diarrhoea—Ifosfamide—testicular cancer	0.000592	0.00118	CcSEcCtD
Dolasetron—Body temperature increased—Cisplatin—testicular cancer	0.00059	0.00117	CcSEcCtD
Dolasetron—Fatigue—Etoposide—testicular cancer	0.000589	0.00117	CcSEcCtD
Dolasetron—Stomatitis—Epirubicin—testicular cancer	0.000585	0.00116	CcSEcCtD
Dolasetron—Jaundice—Epirubicin—testicular cancer	0.000585	0.00116	CcSEcCtD
Dolasetron—Pain—Etoposide—testicular cancer	0.000584	0.00116	CcSEcCtD
Dolasetron—Constipation—Etoposide—testicular cancer	0.000584	0.00116	CcSEcCtD
Dolasetron—Dysuria—Doxorubicin—testicular cancer	0.000583	0.00116	CcSEcCtD
Dolasetron—Haematuria—Epirubicin—testicular cancer	0.000573	0.00114	CcSEcCtD
Dolasetron—Dizziness—Ifosfamide—testicular cancer	0.000572	0.00114	CcSEcCtD
Dolasetron—Epistaxis—Epirubicin—testicular cancer	0.000566	0.00113	CcSEcCtD
Dolasetron—Feeling abnormal—Etoposide—testicular cancer	0.000563	0.00112	CcSEcCtD
Dolasetron—Pneumonia—Doxorubicin—testicular cancer	0.000559	0.00111	CcSEcCtD
Dolasetron—Gastrointestinal pain—Etoposide—testicular cancer	0.000559	0.00111	CcSEcCtD
Dolasetron—Drowsiness—Doxorubicin—testicular cancer	0.000556	0.00111	CcSEcCtD
Dolasetron—Visual impairment—Methotrexate—testicular cancer	0.000555	0.0011	CcSEcCtD
Dolasetron—Hypersensitivity—Cisplatin—testicular cancer	0.000549	0.00109	CcSEcCtD
Dolasetron—Bradycardia—Epirubicin—testicular cancer	0.000549	0.00109	CcSEcCtD
Dolasetron—Rash—Ifosfamide—testicular cancer	0.000545	0.00108	CcSEcCtD
Dolasetron—Dermatitis—Ifosfamide—testicular cancer	0.000545	0.00108	CcSEcCtD
Dolasetron—Urticaria—Etoposide—testicular cancer	0.000543	0.00108	CcSEcCtD
Dolasetron—Stomatitis—Doxorubicin—testicular cancer	0.000542	0.00108	CcSEcCtD
Dolasetron—Jaundice—Doxorubicin—testicular cancer	0.000542	0.00108	CcSEcCtD
Dolasetron—Abdominal pain—Etoposide—testicular cancer	0.00054	0.00107	CcSEcCtD
Dolasetron—Body temperature increased—Etoposide—testicular cancer	0.00054	0.00107	CcSEcCtD
Dolasetron—Tinnitus—Methotrexate—testicular cancer	0.000537	0.00107	CcSEcCtD
Dolasetron—Asthenia—Cisplatin—testicular cancer	0.000535	0.00106	CcSEcCtD
Dolasetron—Oedema peripheral—Epirubicin—testicular cancer	0.000531	0.00106	CcSEcCtD
Dolasetron—Haematuria—Doxorubicin—testicular cancer	0.00053	0.00105	CcSEcCtD
Dolasetron—Epistaxis—Doxorubicin—testicular cancer	0.000524	0.00104	CcSEcCtD
Dolasetron—Visual impairment—Epirubicin—testicular cancer	0.00052	0.00103	CcSEcCtD
Dolasetron—Chills—Methotrexate—testicular cancer	0.000517	0.00103	CcSEcCtD
Dolasetron—Diarrhoea—Cisplatin—testicular cancer	0.00051	0.00101	CcSEcCtD
Dolasetron—Bradycardia—Doxorubicin—testicular cancer	0.000508	0.00101	CcSEcCtD
Dolasetron—Hypersensitivity—Etoposide—testicular cancer	0.000503	0.001	CcSEcCtD
Dolasetron—Tinnitus—Epirubicin—testicular cancer	0.000503	0.001	CcSEcCtD
Dolasetron—Flushing—Epirubicin—testicular cancer	0.0005	0.000995	CcSEcCtD
Dolasetron—Oedema peripheral—Doxorubicin—testicular cancer	0.000491	0.000977	CcSEcCtD
Dolasetron—Dysgeusia—Methotrexate—testicular cancer	0.000491	0.000977	CcSEcCtD
Dolasetron—Asthenia—Etoposide—testicular cancer	0.00049	0.000975	CcSEcCtD
Dolasetron—Chills—Epirubicin—testicular cancer	0.000484	0.000962	CcSEcCtD
Dolasetron—Pruritus—Etoposide—testicular cancer	0.000483	0.000961	CcSEcCtD
Dolasetron—Arrhythmia—Epirubicin—testicular cancer	0.000482	0.000958	CcSEcCtD
Dolasetron—Visual impairment—Doxorubicin—testicular cancer	0.000481	0.000956	CcSEcCtD
Dolasetron—Rash—Cisplatin—testicular cancer	0.00047	0.000935	CcSEcCtD
Dolasetron—Dermatitis—Cisplatin—testicular cancer	0.00047	0.000934	CcSEcCtD
Dolasetron—Diarrhoea—Etoposide—testicular cancer	0.000467	0.00093	CcSEcCtD
Dolasetron—Ill-defined disorder—Methotrexate—testicular cancer	0.000465	0.000925	CcSEcCtD
Dolasetron—Tinnitus—Doxorubicin—testicular cancer	0.000465	0.000925	CcSEcCtD
Dolasetron—Anaemia—Methotrexate—testicular cancer	0.000463	0.000922	CcSEcCtD
Dolasetron—Flushing—Doxorubicin—testicular cancer	0.000463	0.000921	CcSEcCtD
Dolasetron—Flatulence—Epirubicin—testicular cancer	0.000462	0.00092	CcSEcCtD
Dolasetron—Dysgeusia—Epirubicin—testicular cancer	0.00046	0.000914	CcSEcCtD
Dolasetron—Malaise—Methotrexate—testicular cancer	0.000452	0.000899	CcSEcCtD
Dolasetron—Dizziness—Etoposide—testicular cancer	0.000452	0.000899	CcSEcCtD
Dolasetron—Vertigo—Methotrexate—testicular cancer	0.000451	0.000896	CcSEcCtD
Dolasetron—Chills—Doxorubicin—testicular cancer	0.000448	0.00089	CcSEcCtD
Dolasetron—Arrhythmia—Doxorubicin—testicular cancer	0.000446	0.000886	CcSEcCtD
Dolasetron—Cough—Methotrexate—testicular cancer	0.000438	0.00087	CcSEcCtD
Dolasetron—Ill-defined disorder—Epirubicin—testicular cancer	0.000435	0.000866	CcSEcCtD
Dolasetron—Convulsion—Methotrexate—testicular cancer	0.000434	0.000864	CcSEcCtD
Dolasetron—Anaemia—Epirubicin—testicular cancer	0.000434	0.000863	CcSEcCtD
Dolasetron—Agitation—Epirubicin—testicular cancer	0.000431	0.000858	CcSEcCtD
Dolasetron—Rash—Etoposide—testicular cancer	0.000431	0.000857	CcSEcCtD
Dolasetron—Dermatitis—Etoposide—testicular cancer	0.00043	0.000856	CcSEcCtD
Dolasetron—Headache—Etoposide—testicular cancer	0.000428	0.000851	CcSEcCtD
Dolasetron—Flatulence—Doxorubicin—testicular cancer	0.000428	0.000851	CcSEcCtD
Dolasetron—Chest pain—Methotrexate—testicular cancer	0.000427	0.000849	CcSEcCtD
Dolasetron—Myalgia—Methotrexate—testicular cancer	0.000427	0.000849	CcSEcCtD
Dolasetron—Arthralgia—Methotrexate—testicular cancer	0.000427	0.000849	CcSEcCtD
Dolasetron—Dysgeusia—Doxorubicin—testicular cancer	0.000425	0.000846	CcSEcCtD
Dolasetron—Malaise—Epirubicin—testicular cancer	0.000423	0.000842	CcSEcCtD
Dolasetron—Discomfort—Methotrexate—testicular cancer	0.000422	0.000839	CcSEcCtD
Dolasetron—Vertigo—Epirubicin—testicular cancer	0.000422	0.000839	CcSEcCtD
Dolasetron—Syncope—Epirubicin—testicular cancer	0.000421	0.000837	CcSEcCtD
Dolasetron—Palpitations—Epirubicin—testicular cancer	0.000415	0.000825	CcSEcCtD
Dolasetron—Confusional state—Methotrexate—testicular cancer	0.000413	0.000821	CcSEcCtD
Dolasetron—Loss of consciousness—Epirubicin—testicular cancer	0.000412	0.00082	CcSEcCtD
Dolasetron—Cough—Epirubicin—testicular cancer	0.00041	0.000814	CcSEcCtD
Dolasetron—Anaphylactic shock—Methotrexate—testicular cancer	0.000409	0.000814	CcSEcCtD
Dolasetron—Convulsion—Epirubicin—testicular cancer	0.000407	0.000809	CcSEcCtD
Dolasetron—Hypertension—Epirubicin—testicular cancer	0.000405	0.000806	CcSEcCtD
Dolasetron—Ill-defined disorder—Doxorubicin—testicular cancer	0.000403	0.000801	CcSEcCtD
Dolasetron—Anaemia—Doxorubicin—testicular cancer	0.000401	0.000798	CcSEcCtD
Dolasetron—Thrombocytopenia—Methotrexate—testicular cancer	0.000401	0.000797	CcSEcCtD
Dolasetron—Chest pain—Epirubicin—testicular cancer	0.0004	0.000795	CcSEcCtD
Dolasetron—Myalgia—Epirubicin—testicular cancer	0.0004	0.000795	CcSEcCtD
Dolasetron—Arthralgia—Epirubicin—testicular cancer	0.0004	0.000795	CcSEcCtD
Dolasetron—Agitation—Doxorubicin—testicular cancer	0.000399	0.000794	CcSEcCtD
Dolasetron—Anxiety—Epirubicin—testicular cancer	0.000398	0.000792	CcSEcCtD
Dolasetron—Hyperhidrosis—Methotrexate—testicular cancer	0.000396	0.000787	CcSEcCtD
Dolasetron—Discomfort—Epirubicin—testicular cancer	0.000395	0.000785	CcSEcCtD
Dolasetron—Malaise—Doxorubicin—testicular cancer	0.000392	0.000779	CcSEcCtD
Dolasetron—Dry mouth—Epirubicin—testicular cancer	0.000391	0.000777	CcSEcCtD
Dolasetron—Vertigo—Doxorubicin—testicular cancer	0.00039	0.000776	CcSEcCtD
Dolasetron—Anorexia—Methotrexate—testicular cancer	0.00039	0.000776	CcSEcCtD
Dolasetron—Syncope—Doxorubicin—testicular cancer	0.000389	0.000774	CcSEcCtD
Dolasetron—Confusional state—Epirubicin—testicular cancer	0.000386	0.000768	CcSEcCtD
Dolasetron—Palpitations—Doxorubicin—testicular cancer	0.000384	0.000763	CcSEcCtD
Dolasetron—Anaphylactic shock—Epirubicin—testicular cancer	0.000383	0.000762	CcSEcCtD
Dolasetron—Oedema—Epirubicin—testicular cancer	0.000383	0.000762	CcSEcCtD
Dolasetron—Hypotension—Methotrexate—testicular cancer	0.000382	0.000761	CcSEcCtD
Dolasetron—Loss of consciousness—Doxorubicin—testicular cancer	0.000382	0.000759	CcSEcCtD
Dolasetron—Cough—Doxorubicin—testicular cancer	0.000379	0.000754	CcSEcCtD
Dolasetron—Shock—Epirubicin—testicular cancer	0.000377	0.000749	CcSEcCtD
Dolasetron—Convulsion—Doxorubicin—testicular cancer	0.000376	0.000748	CcSEcCtD
Dolasetron—Thrombocytopenia—Epirubicin—testicular cancer	0.000375	0.000746	CcSEcCtD
Dolasetron—Hypertension—Doxorubicin—testicular cancer	0.000375	0.000746	CcSEcCtD
Dolasetron—Tachycardia—Epirubicin—testicular cancer	0.000374	0.000743	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000373	0.000742	CcSEcCtD
Dolasetron—Hyperhidrosis—Epirubicin—testicular cancer	0.00037	0.000736	CcSEcCtD
Dolasetron—Myalgia—Doxorubicin—testicular cancer	0.00037	0.000735	CcSEcCtD
Dolasetron—Chest pain—Doxorubicin—testicular cancer	0.00037	0.000735	CcSEcCtD
Dolasetron—Arthralgia—Doxorubicin—testicular cancer	0.00037	0.000735	CcSEcCtD
Dolasetron—Anxiety—Doxorubicin—testicular cancer	0.000368	0.000733	CcSEcCtD
Dolasetron—Paraesthesia—Methotrexate—testicular cancer	0.000367	0.000731	CcSEcCtD
Dolasetron—Discomfort—Doxorubicin—testicular cancer	0.000365	0.000726	CcSEcCtD
Dolasetron—Anorexia—Epirubicin—testicular cancer	0.000365	0.000726	CcSEcCtD
Dolasetron—Dyspnoea—Methotrexate—testicular cancer	0.000365	0.000726	CcSEcCtD
Dolasetron—Somnolence—Methotrexate—testicular cancer	0.000364	0.000724	CcSEcCtD
Dolasetron—Dry mouth—Doxorubicin—testicular cancer	0.000362	0.000719	CcSEcCtD
Dolasetron—Dyspepsia—Methotrexate—testicular cancer	0.00036	0.000717	CcSEcCtD
Dolasetron—Hypotension—Epirubicin—testicular cancer	0.000358	0.000712	CcSEcCtD
Dolasetron—Confusional state—Doxorubicin—testicular cancer	0.000357	0.000711	CcSEcCtD
Dolasetron—Decreased appetite—Methotrexate—testicular cancer	0.000356	0.000708	CcSEcCtD
Dolasetron—Anaphylactic shock—Doxorubicin—testicular cancer	0.000354	0.000705	CcSEcCtD
Dolasetron—Oedema—Doxorubicin—testicular cancer	0.000354	0.000705	CcSEcCtD
Dolasetron—Fatigue—Methotrexate—testicular cancer	0.000353	0.000702	CcSEcCtD
Dolasetron—Pain—Methotrexate—testicular cancer	0.00035	0.000696	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000349	0.000694	CcSEcCtD
Dolasetron—Shock—Doxorubicin—testicular cancer	0.000349	0.000693	CcSEcCtD
Dolasetron—Thrombocytopenia—Doxorubicin—testicular cancer	0.000347	0.00069	CcSEcCtD
Dolasetron—Tachycardia—Doxorubicin—testicular cancer	0.000346	0.000688	CcSEcCtD
Dolasetron—Paraesthesia—Epirubicin—testicular cancer	0.000344	0.000684	CcSEcCtD
Dolasetron—Hyperhidrosis—Doxorubicin—testicular cancer	0.000343	0.000681	CcSEcCtD
Dolasetron—Dyspnoea—Epirubicin—testicular cancer	0.000341	0.000679	CcSEcCtD
Dolasetron—Somnolence—Epirubicin—testicular cancer	0.00034	0.000677	CcSEcCtD
Dolasetron—Anorexia—Doxorubicin—testicular cancer	0.000338	0.000672	CcSEcCtD
Dolasetron—Feeling abnormal—Methotrexate—testicular cancer	0.000337	0.000671	CcSEcCtD
Dolasetron—Dyspepsia—Epirubicin—testicular cancer	0.000337	0.000671	CcSEcCtD
Dolasetron—Gastrointestinal pain—Methotrexate—testicular cancer	0.000335	0.000666	CcSEcCtD
Dolasetron—Decreased appetite—Epirubicin—testicular cancer	0.000333	0.000662	CcSEcCtD
Dolasetron—Hypotension—Doxorubicin—testicular cancer	0.000331	0.000659	CcSEcCtD
Dolasetron—Fatigue—Epirubicin—testicular cancer	0.00033	0.000657	CcSEcCtD
Dolasetron—Constipation—Epirubicin—testicular cancer	0.000328	0.000651	CcSEcCtD
Dolasetron—Pain—Epirubicin—testicular cancer	0.000328	0.000651	CcSEcCtD
Dolasetron—Urticaria—Methotrexate—testicular cancer	0.000325	0.000647	CcSEcCtD
Dolasetron—Abdominal pain—Methotrexate—testicular cancer	0.000324	0.000643	CcSEcCtD
Dolasetron—Body temperature increased—Methotrexate—testicular cancer	0.000324	0.000643	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000323	0.000642	CcSEcCtD
Dolasetron—Paraesthesia—Doxorubicin—testicular cancer	0.000318	0.000633	CcSEcCtD
Dolasetron—Dyspnoea—Doxorubicin—testicular cancer	0.000316	0.000628	CcSEcCtD
Dolasetron—Feeling abnormal—Epirubicin—testicular cancer	0.000316	0.000628	CcSEcCtD
Dolasetron—Somnolence—Doxorubicin—testicular cancer	0.000315	0.000627	CcSEcCtD
Dolasetron—Gastrointestinal pain—Epirubicin—testicular cancer	0.000313	0.000623	CcSEcCtD
Dolasetron—Dyspepsia—Doxorubicin—testicular cancer	0.000312	0.00062	CcSEcCtD
Dolasetron—Decreased appetite—Doxorubicin—testicular cancer	0.000308	0.000613	CcSEcCtD
Dolasetron—Fatigue—Doxorubicin—testicular cancer	0.000306	0.000608	CcSEcCtD
Dolasetron—Urticaria—Epirubicin—testicular cancer	0.000304	0.000605	CcSEcCtD
Dolasetron—Constipation—Doxorubicin—testicular cancer	0.000303	0.000603	CcSEcCtD
Dolasetron—Pain—Doxorubicin—testicular cancer	0.000303	0.000603	CcSEcCtD
Dolasetron—Abdominal pain—Epirubicin—testicular cancer	0.000303	0.000602	CcSEcCtD
Dolasetron—Body temperature increased—Epirubicin—testicular cancer	0.000303	0.000602	CcSEcCtD
Dolasetron—Hypersensitivity—Methotrexate—testicular cancer	0.000302	0.0006	CcSEcCtD
Dolasetron—Asthenia—Methotrexate—testicular cancer	0.000294	0.000584	CcSEcCtD
Dolasetron—Feeling abnormal—Doxorubicin—testicular cancer	0.000292	0.000581	CcSEcCtD
Dolasetron—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00029	0.000576	CcSEcCtD
Dolasetron—Pruritus—Methotrexate—testicular cancer	0.00029	0.000576	CcSEcCtD
Dolasetron—Hypersensitivity—Epirubicin—testicular cancer	0.000282	0.000561	CcSEcCtD
Dolasetron—Urticaria—Doxorubicin—testicular cancer	0.000282	0.00056	CcSEcCtD
Dolasetron—Body temperature increased—Doxorubicin—testicular cancer	0.00028	0.000557	CcSEcCtD
Dolasetron—Abdominal pain—Doxorubicin—testicular cancer	0.00028	0.000557	CcSEcCtD
Dolasetron—Diarrhoea—Methotrexate—testicular cancer	0.00028	0.000557	CcSEcCtD
Dolasetron—Asthenia—Epirubicin—testicular cancer	0.000275	0.000547	CcSEcCtD
Dolasetron—Pruritus—Epirubicin—testicular cancer	0.000271	0.000539	CcSEcCtD
Dolasetron—Dizziness—Methotrexate—testicular cancer	0.000271	0.000538	CcSEcCtD
Dolasetron—Diarrhoea—Epirubicin—testicular cancer	0.000262	0.000521	CcSEcCtD
Dolasetron—Hypersensitivity—Doxorubicin—testicular cancer	0.000261	0.000519	CcSEcCtD
Dolasetron—Rash—Methotrexate—testicular cancer	0.000258	0.000513	CcSEcCtD
Dolasetron—Dermatitis—Methotrexate—testicular cancer	0.000258	0.000513	CcSEcCtD
Dolasetron—Headache—Methotrexate—testicular cancer	0.000256	0.00051	CcSEcCtD
Dolasetron—Asthenia—Doxorubicin—testicular cancer	0.000254	0.000506	CcSEcCtD
Dolasetron—Dizziness—Epirubicin—testicular cancer	0.000253	0.000504	CcSEcCtD
Dolasetron—Pruritus—Doxorubicin—testicular cancer	0.000251	0.000499	CcSEcCtD
Dolasetron—Diarrhoea—Doxorubicin—testicular cancer	0.000242	0.000482	CcSEcCtD
Dolasetron—Rash—Epirubicin—testicular cancer	0.000241	0.00048	CcSEcCtD
Dolasetron—Dermatitis—Epirubicin—testicular cancer	0.000241	0.00048	CcSEcCtD
Dolasetron—Headache—Epirubicin—testicular cancer	0.00024	0.000477	CcSEcCtD
Dolasetron—Dizziness—Doxorubicin—testicular cancer	0.000234	0.000466	CcSEcCtD
Dolasetron—Rash—Doxorubicin—testicular cancer	0.000223	0.000444	CcSEcCtD
Dolasetron—Dermatitis—Doxorubicin—testicular cancer	0.000223	0.000444	CcSEcCtD
Dolasetron—Headache—Doxorubicin—testicular cancer	0.000222	0.000442	CcSEcCtD
